Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Lv T, Shen L, Xu X, Yao Y, Mu P, Zhang H, Wan J, Wang Y, Guan R, Li X, Fu G, Zhang L, Wang Y, Xia F, Hu C, Clevers H, Zhang Z, Hua G.
Lv T, et al. Among authors: wan j.
Int J Cancer. 2023 Feb 1;152(3):524-535. doi: 10.1002/ijc.34302. Epub 2022 Oct 5.
Int J Cancer. 2023.
PMID: 36161653